for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cardinal Health Inc

CAH

Latest Trade

47.22USD

Change

0.82(+1.76%)

Volume

1,196,730

Today's Range

46.34

 - 

47.38

52 Week Range

39.05

 - 

60.69

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
46.40
Open
46.59
Volume
1,196,730
3M AVG Volume
49.74
Today's High
47.38
Today's Low
46.34
52 Week High
60.69
52 Week Low
39.05
Shares Out (MIL)
292.44
Market Cap (MIL)
13,396.86
Forward P/E
8.37
Dividend (Yield %)
4.24

Next Event

Dividend For CAH.N - 0.4859 USD

Latest Developments

More

U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ

Cardinal Health Says Expects 2021 Non-Gaap EPS In Range Of $5.25 To $5.65

Cardinal Health - Sees Mid-Single Digit Percentage Decline In 2020 Pharmaceutical Segment Profit - Presentation

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Industry

Biotechnology & Drugs

Contact Info

7000 Cardinal Pl

DUBLIN, OH

43017-1091

United States

+1.614.7573033

https://www.cardinalhealth.com/

Executive Leadership

Gregory B. Kenny

Non-Executive Chairman of the Board

Michael C. Kaufmann

Chief Executive Officer, Director

Jason M. Hollar

Chief Financial Officer

Victor L. Crawford

Chief Executive Officer - Pharmaceutical segment

Stephen M. Mason

Chief Executive Officer-Medical Segment

Key Stats

2.68 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

136.8K

2019

145.5K

2020

152.9K

2021(E)

159.8K
EPS (USD)

2018

5.000

2019

5.280

2020

5.450

2021(E)

5.480
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.09
Price To Book (MRQ)
7.50
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
378.70
LT Debt To Equity (MRQ)
378.14
Return on Investment (TTM)
-21.72
Return on Equity (TTM)
-9.04

Latest News

Latest News

BRIEF-Cardinal Health Says Dave Evans To Join Board Of Directors

* DAVE EVANS TO JOIN CARDINAL HEALTH BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Robbins Geller picked to lead investor case against Cardinal Health

Robbins Geller Rudman & Dowd has beat out two other top plaintiffs firms for the job of lead counsel in a proposed class action alleging Cardinal Health Inc misled investors about problems at a medical device maker it bought.

BRIEF-Cardinal Health Announces Redemption Of Outstanding Notes

* CARDINAL HEALTH INC - SENDING IRREVOCABLE NOTICE OF EARLY REDEMPTION TO HOLDERS OF CO'S $500 MILLION 4.625% NOTES DUE 2020

BRIEF-Cardinal Health - Sees Mid-Single Digit Percentage Decline In 2020 Pharmaceutical Segment Profit - Presentation

* CARDINAL HEALTH - SEES MID-SINGLE DIGIT PERCENTAGE DECLINE IN 2020 PHARMACEUTICAL SEGMENT PROFIT - PRESENTATION Source text for Eikon: Further company coverage:

BRIEF-Cardinal Health Reports Q3 Results For Fiscal Year 2020

* CARDINAL HEALTH REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2020

BRIEF-Cardinal Health - Jason Hollar Will Receive A Base Salary Of $700,000

* CARDINAL HEALTH - JASON HOLLAR WILL RECEIVE A BASE SALARY OF $700,000 Source text for Eikon: https://bit.ly/2IYvLGH Further company coverage:

BRIEF-Cardinal Health Names Jason Hollar As New Chief Financial Officer

* CARDINAL HEALTH NAMES JASON HOLLAR AS NEW CHIEF FINANCIAL OFFICER

IN BRIEF: Arent Fox hires Cardinal Health's in-house IP counsel

The top in-house intellectual property lawyer at drug wholesaler and medical supplier Cardinal Health Inc has moved to Arent Fox, the law firm said on Tuesday.

Cardinal Health Inc wins $2.25 billion U.S. defense contract: Pentagon

Cardinal Health 200 LLC, a unit of Cardinal Health Inc <CAH.N>, has been awarded a maximum $2.25 billion modification for a contract with the Defense Logistics Agency for ordering and distribution of medical surgical supplies, the Pentagon said on Thursday.

Cardinal Health top lawyer's pay nears $3 mln as opioid suits pile up

Cardinal Health Inc.'s top in-house lawyer's compensation for 2019 totaled nearly $3 million, according to a proxy the drug distributor has filed with the U.S. Securities and Exchange Commission.

Cardinal Health warns ongoing opioid-related lawsuits to hit business

Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.

Cardinal Health says opioid-related lawsuits to hurt business

Drug distributor Cardinal Health Inc warned on Tuesday that its business could take a hit as it defends itself against a host of opioid-related lawsuits.

U.S. Drug distributors propose $10 billion to end state lawsuits over opioids: Bloomberg

Drug wholesalers AmerisourceBergen Corp <ABC.N>, McKesson Corp <MCK.N> and Cardinal Health Inc <CAH.N> have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations...

Cardinal Health must turn over suspicious-drug audit in opioid MDL

Cardinal Health Inc has lost a bid to avoid turning over the results of a 2008 audit of its system for identifying suspicious drug orders to lawyers for two Ohio counties who claim the drug wholesale distributor helped fuel the opioid epidemic.

UPDATE 1-Drug distributor Cardinal's profit beats on pharma unit strength

U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its pharmaceutical and medical devices businesses.

Cardinal Health posts fourth-quarter loss

Cardinal Health Inc reported a fourth-quarter loss compared to a year-ago profit, as the U.S. drug distributor was hit by an asset-impairment charge of $1.35 billion.

Cardinal Health misses profit on Cordis woes, shares fall

Cardinal Health Inc's <CAH.N> quarterly profit missed analysts' expectations as inventory and cost issues hurt its Cordis medical device unit, and the U.S. drug distributor said it saw prices of generic drugs fall more than expected.

Drug distributor Cardinal Health's quarterly profit falls 33 pct

U.S. drug distributor Cardinal Health Inc posted a 33 percent fall in quarterly profit on Thursday, hurt by a change in the company's effective tax rate primarily associated with its Cordis business.

BRIEF-Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39

* CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2018

BRIEF-Cardinal Health Recommends Shareholders Reject The Below-Market Mini-Tender Offer By TRC Capital Corporation

* CARDINAL HEALTH RECOMMENDS SHAREHOLDERS REJECT THE BELOW-MARKET MINI-TENDER OFFER BY TRC CAPITAL CORPORATION

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up